INCB-47986

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameINCB-47986
Drug Alias NameINCB-47986 INCB-047986
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK1 inhibitors
TargetsTyrosine-protein kinase JAK1
Therapy Area/IndicationsSolid tumoursMyelodysplastic SyndromesArthritis, Rheumatoid +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIncyte Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIncyte Corp
Active IndicationsN/A
Inactive IndicationsSolid tumoursMyelodysplastic SyndromesArthritis, Rheumatoid +[9] 

Other Information

ATC CodeN/A
Related LinksN/A